Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ann Kim Novakowski"'
Autor:
Seth Rowley, Pat Garcia-Gonzalez, Jerald P. Radich, Ann Kim Novakowski, Irina Usherenko, Joseph B. Babigumira
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Purpose To estimate the resource gap in the polymerase chain reaction (PCR) monitoring for patients with chronic myeloid leukemia (CML) in low- and middle-income countries (LMICs). Methods We developed a model of demand and supply of PCR mon
Externí odkaz:
https://doaj.org/article/9a67a2fcc9e14ad592b545c83ce441b8
Publikováno v:
Globalization and Health, Vol 14, Iss 1, Pp 1-10 (2018)
Abstract Background Cancer is a major burden of disease in low- and middle-income countries (LMICs) yet financial barriers limit access to life-saving oncology drugs. Medical donation and other drug access programs can help improve patient access to
Externí odkaz:
https://doaj.org/article/dfa12dccee4a4a93b6df6e6cbdbe5252
Autor:
Jerald P. Radich, Irina Usherenko, Pat Garcia-Gonzalez, Ann Kim Novakowski, Joseph B. Babigumira, Seth S. Rowley
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-8 (2021)
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation : C/E
Purpose To estimate the resource gap in the polymerase chain reaction (PCR) monitoring for patients with chronic myeloid leukemia (CML) in low- and middle-income countries (LMICs). Methods We developed a model of demand and supply of PCR monitoring o
Publikováno v:
Globalization and Health
Globalization and Health, Vol 14, Iss 1, Pp 1-10 (2018)
Globalization and Health, Vol 14, Iss 1, Pp 1-10 (2018)
Background Cancer is a major burden of disease in low- and middle-income countries (LMICs) yet financial barriers limit access to life-saving oncology drugs. Medical donation and other drug access programs can help improve patient access to essential
Publikováno v:
Journal of Global Oncology. 4:29s-29s
Purpose The Max Foundation has led the development and implementation of the widely recognized model for patient assistance programs by which manufacturers make available some of their innovative products to patients in low- and middle-income countri